Cargando…

Plasma metabolomic profiling in subclinical atherosclerosis: the Diabetes Heart Study

BACKGROUND: Incidence rates of cardiovascular disease (CVD) are increasing, partly driven by the diabetes epidemic. Novel prediction tools and modifiable treatment targets are needed to enhance risk assessment and management. Plasma metabolite associations with subclinical atherosclerosis were inves...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chevli, Parag Anilkumar, Freedman, Barry I., Hsu, Fang-Chi, Xu, Jianzhao, Rudock, Megan E., Ma, Lijun, Parks, John S., Palmer, Nicholette D., Shapiro, Michael D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8653597/ https://www.ncbi.nlm.nih.gov/pubmed/34876126 http://dx.doi.org/10.1186/s12933-021-01419-y

Ejemplares similares

Subclinical Atherosclerosis Is Inversely Associated With Gray Matter Volume in African Americans With Type 2 Diabetes
por: Freedman, Barry I., et al.
Publicado: (2015)

Human Lipoxygenase Pathway Gene Variation and Association with Markers of Subclinical Atherosclerosis in the Diabetes Heart Study
por: Burdon, Kathryn P., et al.
Publicado: (2010)

Chemerin is not associated with subclinical atherosclerosis markers in prediabetes and diabetes
por: Aydın, Kadriye, et al.
Publicado: (2016)

Normal-weight obesity is associated with increased risk of subclinical atherosclerosis
por: Kim, Sohee, et al.
Publicado: (2015)

Differential impact of metabolic syndrome on subclinical atherosclerosis according to the presence of diabetes
por: Won, Ki-Bum, et al.
Publicado: (2013)

Associations Between Life-Course Lipid Trajectories and Subclinical Atherosclerosis in Midlife
por: Yan, Yinkun, et al.
Publicado: (2022)

Glycemic variability is associated with subclinical atherosclerosis in Chinese type 2 diabetic patients
por: Mo, Yifei, et al.
Publicado: (2013)

Serum gamma-glutamyltransferase is not associated with subclinical atherosclerosis in patients with type 2 diabetes
por: Yoon, Hye Eun, et al.
Publicado: (2016)

Association of Childhood Oral Infections With Cardiovascular Risk Factors and Subclinical Atherosclerosis in Adulthood
por: Pussinen, Pirkko J., et al.
Publicado: (2019)

Variability of the Plasma Lipidome and Subclinical Coronary Atherosclerosis
por: Tan, Sock Hwee, et al.
Publicado: (2021)

Assessment of plasma ceramides as predictor for subclinical atherosclerosis
por: Mishra, Pashupati P., et al.
Publicado: (2021)

Diabetic retinopathy is associated with the presence and burden of subclinical carotid atherosclerosis in type 1 diabetes
por: Carbonell, Marc, et al.
Publicado: (2018)

Subclinical atherosclerosis burden predicts cardiovascular events in individuals with diabetes and chronic kidney disease
por: Palanca, Ana, et al.
Publicado: (2019)

APOL1 associations with nephropathy, atherosclerosis, and all-cause mortality in African Americans with type 2 diabetes
por: Freedman, Barry I., et al.
Publicado: (2014)

Plasma IL-5 concentration and subclinical carotid atherosclerosis
por: Silveira, Angela, et al.
Publicado: (2015)

Association Between Alcohol Consumption and Ectopic Fat in the Multi‐Ethnic Study of Atherosclerosis
por: Kazibwe, Richard, et al.
Publicado: (2023)

Serum fibroblast growth factor 21 levels are related to subclinical atherosclerosis in patients with type 2 diabetes
por: Xiao, Yang, et al.
Publicado: (2015)

Relation between high serum hepcidin-25 level and subclinical atherosclerosis and cardiovascular mortality in hemodialysis patients
por: Yayar, Özlem, et al.
Publicado: (2018)

Interrelationships Between American Heart Association's Life's Simple 7, ECG Silent Myocardial Infarction, and Cardiovascular Mortality
por: Ahmad, Muhammad Imtiaz, et al.
Publicado: (2019)

Associations of coronary artery calcified plaque density with mortality in type 2 diabetes: the Diabetes Heart Study
por: Raffield, Laura M., et al.
Publicado: (2018)

Associations between epicardial adipose tissue, subclinical atherosclerosis and high-density lipoprotein composition in type 1 diabetes
por: Colom, Cristina, et al.
Publicado: (2018)

Serum sclerostin level and its relation to subclinical atherosclerosis in the polycystic ovary syndrome phenotypes: A prospective controlled study
por: İncesu Çintesun, Feyza Nur, et al.
Publicado: (2021)

Unbiased plasma proteomics discovery of biomarkers for improved detection of subclinical atherosclerosis
por: Núñez, Estefanía, et al.
Publicado: (2022)

Gender difference in the association between TyG index and subclinical atherosclerosis: results from the I-Lan Longitudinal Aging Study
por: Lu, Ya-Wen, et al.
Publicado: (2021)

Relationship of YKL-40 and adiponectin and subclinical atherosclerosis in asymptomatic patients with type 1 diabetes mellitus from a European Mediterranean population
por: Aguilera, Eva, et al.
Publicado: (2015)

Aortic flow propagation velocity, epicardial fat thickness, and osteoprotegerin level to predict subclinical atherosclerosis in patients with nonalcoholic fatty liver disease
por: Oğuz, Didem, et al.
Publicado: (2016)

FGF23 Concentration and APOL1 Genotype Are Novel Predictors of Mortality in African Americans With Type 2 Diabetes
por: Chan, Gary C., et al.
Publicado: (2018)

Biomarkers of subclinical atherosclerosis in patients with psoriasis
por: Kaiser, Hannah, et al.
Publicado: (2021)

Subclinical atherosclerosis in patients with psoriasis
por: Balta, Ilknur, et al.
Publicado: (2015)

Diabetes and Subclinical Coronary Atherosclerosis
por: Lee, Chang Hoon, et al.
Publicado: (2018)

Predictors of subclinical atherosclerosis in HIV
por: Fernández Soto, Julia, et al.
Publicado: (2023)

Metabolomic profiling of glucose homeostasis in African Americans: the Insulin Resistance Atherosclerosis Family Study (IRAS-FS)
por: Okut, Hayrettin, et al.
Publicado: (2023)

Prescription of Lipid-Lowering and Antihypertensive Drugs Following Pictorial Information About Subclinical Atherosclerosis: A Secondary Outcome of a Randomized Clinical Trial
por: Sjölander, Maria, et al.
Publicado: (2021)

Plasma Metabolomics Reveals Systemic Metabolic Alterations of Subclinical and Clinical Hypothyroidism
por: Shao, Feifei, et al.
Publicado: (2022)

Triglyceride-mediated influence of serum angiopoietin-like protein 8 on subclinical atherosclerosis in type 2 diabetic patients: results from the GDMD study in China
por: Zheng, Tianpeng, et al.
Publicado: (2018)

Associations between retinol-binding protein 4 and cardiometabolic risk factors and subclinical atherosclerosis in recently postmenopausal women: cross-sectional analyses from the KEEPS study
por: Huang, Gary, et al.
Publicado: (2012)

Noninvasive indicators of atherosclerosis in subclinical hypothyroidism
por: Kilic, Ismail Dogu, et al.
Publicado: (2013)

Association of Fat Density With Subclinical Atherosclerosis
por: Alvey, Nicholas J., et al.
Publicado: (2014)

Subclinical atherosclerosis: how and when to treat it?
por: Gatto, Laura, et al.
Publicado: (2020)

An Exome-wide Association Study for Type 2 Diabetes–Attributed End-Stage Kidney Disease in African Americans
por: Guan, Meijian, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_6156scluv383katitn2570relc